Literature DB >> 15178577

Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.

Salim Dhanji1, Soo-Jeet Teh, Darryl Oble, John J Priatel, Hung-Sia Teh.   

Abstract

We have recently shown that interleukin-2 (IL-2)-activated CD8(+)CD44(hi) cells from normal mice express both adaptive and innate immune system receptors and specifically kill syngeneic tumor cells, particularly those that express NKG2D ligands. Here we show that CD8+ T cells from antigen-expressing H-Y T-cell receptor (TCR) transgenic mice also exhibit characteristics of both T cells and natural killer (NK) cells. Interaction with cognate self-antigen was required for the optimal expansion of these cells in peripheral lymphoid tissues. Although these cells possess a higher activation threshold relative to naive T cells, they can be activated by cytokine alone in vitro. They also undergo bystander proliferation in response to a bacterial infection in vivo. Interestingly, upon activation, the cells express the NKG2D receptor as well as the DNAX activation protein 12 (DAP12) adaptor protein. We provide evidence that NKG2D can act additively with the TCR in the killing of target cells, and it can also function as a directly activating receptor in non-major histocompatibility complex (MHC)-restricted killing of target cells. These properties of CD8+ T cells from H-Y TCR transgenic mice are remarkably similar to CD8(+)CD44(hi) cells that are found in normal mice. The H-Y TCR transgenic mice provide a well-defined system for characterizing the developmental biology and function of these cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178577     DOI: 10.1182/blood-2004-01-0150

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  ITK and IL-15 support two distinct subsets of CD8+ T cells.

Authors:  Sigrid Dubois; Thomas A Waldmann; Jürgen R Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

2.  The ThPOK transcription factor differentially affects the development and function of self-specific CD8(+) T cells and regulatory CD4(+) T cells.

Authors:  Yuh-Ching Twu; Hung-Sia Teh
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

3.  Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.

Authors:  Julia K Tietze; Danice E C Wilkins; Gail D Sckisel; Myriam N Bouchlaka; Kory L Alderson; Jonathan M Weiss; Erik Ames; Kevin W Bruhn; Noah Craft; Robert H Wiltrout; Dan L Longo; Lewis L Lanier; Bruce R Blazar; Doug Redelman; William J Murphy
Journal:  Blood       Date:  2012-01-17       Impact factor: 22.113

Review 4.  DAP10- and DAP12-associated receptors in innate immunity.

Authors:  Lewis L Lanier
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

5.  Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.

Authors:  Hongbin Wang; Carol Hoffman; Xinghong Yang; Beata Clapp; David W Pascual
Journal:  PLoS Pathog       Date:  2020-01-17       Impact factor: 6.823

6.  Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells.

Authors:  F Haspot; H W Li; C L Lucas; T Fehr; S Beyaz; M Sykes
Journal:  Am J Transplant       Date:  2013-12-04       Impact factor: 8.086

Review 7.  Tumor antigen-dependent and tumor antigen-independent activation of antitumor activity in T cells by a bispecific antibody-modified tumor vaccine.

Authors:  Philippe Fournier; Volker Schirrmacher
Journal:  Clin Dev Immunol       Date:  2011-03-01

8.  Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.

Authors:  Arta M Monjazeb; Julia K Tietze; Steven K Grossenbacher; Hui-Hua Hsiao; Anthony E Zamora; Annie Mirsoian; Brent Koehn; Bruce R Blazar; Jonathan M Weiss; Robert H Wiltrout; Gail D Sckisel; William J Murphy
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

9.  Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of HFE as a negative regulator of CD8+ T-lymphocyte activation and differentiation in vivo.

Authors:  Mónica Costa; Eugénia Cruz; Susana Oliveira; Vladimir Benes; Tomi Ivacevic; Maria João Silva; Inês Vieira; Francisco Dias; Sónia Fonseca; Marta Gonçalves; Margarida Lima; Catarina Leitão; Martina U Muckenthaler; Jorge Pinto; Graça Porto
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

10.  Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies.

Authors:  Arta Monir Monjazeb; Anthony E Zamora; Steven K Grossenbacher; Annie Mirsoian; Gail D Sckisel; William J Murphy
Journal:  Front Oncol       Date:  2013-07-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.